Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, PI3K/AKT/mTOR signaling in cancer, and Colorectal Cancer Treatments and Studies.
ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group
RECIST 1.1—Update and clarification: From the RECIST committee
RECIST 1.1 – Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group
Response assessment criteria for brain metastases: proposal from the RANO group
Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group
Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group
A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02